
GC71534
CGP-35949 sodium
Also known as sodium N-[5-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-chloro-2-methylphenyl]-1,2,3-triaza-4-azanidacyclopenta-2,5-diene-5-carboxamide
CGP-35949 sodium is a LTD4 antagonist with phospholipase inhibitory activity
ChemicalCAS111130-13-3MW509.92FormulaC23H25ClN5NaO5
- CAS number
- 111130-13-3
- Molecular weight
- 509.92
- Formula
- C23H25ClN5NaO5
- InChIKey
- CJDFUZGGLMRUHB-UHFFFAOYSA-M
- Catalogue number
- GC71534
- Brand
- GLPBIO
Computed properties PubChem CID 23693560 · TPSA 125 Ų · H-bond donors 2 · H-bond acceptors 9
- TPSA
- 125 Ų
- H-bond donors
- 2
- H-bond acceptors
- 9
- Rotatable bonds
- 11
- Heavy atoms
- 35
SMILES CCCC1=C(C=CC(=C1O)C(=O)C)OCCCOC2=C(C=C(C(=C2)NC(=O)C3=NN=N[N-]3)C)Cl.[Na+]
Computed descriptors from PubChem (CID 23693560), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il